PAVmed (PAVM) Revenue Growth (1y) (2022 - 2025)
PAVmed (PAVM) Revenue Growth (1y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.30 Bn | 175.00 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 128.77 Bn | 125.89 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 67.85 Bn | 66.39 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 48.12 Bn | 44.45 Bn | 1.29 Bn | 16.70% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 15.05% |
| 7 | GE HealthCare Technologies | 27.98 Bn | 25.70 Bn | 1.98 Bn | 7.41% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.78 Bn | 20.65 Bn | 2.07 Bn | 6.08% |
| 10 | PAVmed | 11.35 Mn | 9.81 Mn | -4,000.00 | 710.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 710.00% |
| Jun 30, 2025 | -99.39% |
| Mar 31, 2025 | -99.21% |
| Dec 31, 2024 | -99.05% |
| Jun 30, 2024 | 489.76% |
| Mar 31, 2024 | 126.46% |
| Dec 31, 2023 | 836.61% |
| Sep 30, 2023 | 940.79% |
| Mar 31, 2023 | 135.98% |
| Dec 31, 2022 | -62.67% |
| Sep 30, 2022 | -62.00% |